These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17687136)

  • 1. Prophylactic treatment for prevention of joint disease in hemophilia--cost versus benefit.
    Roosendaal G; Lafeber F
    N Engl J Med; 2007 Aug; 357(6):603-5. PubMed ID: 17687136
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness--can it be measured?
    Bohn RL; Avorn J
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):20-3. PubMed ID: 8367739
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for the benefits of prophylaxis in the management of hemophilia A.
    Hoots WK; Nugent DJ
    Thromb Haemost; 2006 Oct; 96(4):433-40. PubMed ID: 17003919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
    Manco-Johnson MJ; Abshire TC; Shapiro AD; Riske B; Hacker MR; Kilcoyne R; Ingram JD; Manco-Johnson ML; Funk S; Jacobson L; Valentino LA; Hoots WK; Buchanan GR; DiMichele D; Recht M; Brown D; Leissinger C; Bleak S; Cohen A; Mathew P; Matsunaga A; Medeiros D; Nugent D; Thomas GA; Thompson AA; McRedmond K; Soucie JM; Austin H; Evatt BL
    N Engl J Med; 2007 Aug; 357(6):535-44. PubMed ID: 17687129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
    Roosendaal G; Lafeber FP
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of joint bleeding in hemophilia.
    Simpson ML; Valentino LA
    Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
    Nilsson IM
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to target joint bleeding in hemophilia: prophylaxis for all or individualized treatment?
    Abshire T
    J Pediatr; 2004 Nov; 145(5):581-3. PubMed ID: 15520752
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment.
    Roosendaal G; Jansen NW; Schutgens R; Lafeber FP
    Haemophilia; 2008 Nov; 14 Suppl 6():4-10. PubMed ID: 19134026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].
    He WW; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):636-8. PubMed ID: 23158747
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing outcomes for patients with severe haemophilia A.
    Pipe SW; Valentino LA
    Haemophilia; 2007 Nov; 13 Suppl 4():1-16; quiz 3 p following 16. PubMed ID: 17822512
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
    Tagliaferri A; Feola G; Molinari AC; Santoro C; Rivolta GF; Cultrera DB; Gagliano F; Zanon E; Mancuso ME; Valdré L; Mameli L; Amoresano S; Mathew P; Coppola A;
    Thromb Haemost; 2015 Jul; 114(1):35-45. PubMed ID: 25855376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To bleed or not to bleed - is that a question?
    Aledort LM
    J Thromb Haemost; 2010 Jan; 8(1):81-2. PubMed ID: 19874456
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis in adults with haemophilia.
    Hay CR
    Haemophilia; 2007 Sep; 13 Suppl 2():10-5. PubMed ID: 17685918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of arthropathy in haemophilia - intensive on-demand treatment, UK perspective.
    Lee CA
    Haemophilia; 2008 Nov; 14 Suppl 6():11-5. PubMed ID: 19134027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower doses of factor VIII for hemophilia.
    Penner JA; Kelly PE
    N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.
    Daliri AA; Haghparast H; Mamikhani J
    Int J Technol Assess Health Care; 2009 Oct; 25(4):584-7. PubMed ID: 19845990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.
    Smejkal P; Brabec P; Matyskova M; Bulikova A; Slechtova M; Kissova J; Chlupova G; Muzik J; Penka M
    Haemophilia; 2009 May; 15(3):743-51. PubMed ID: 19432925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.